These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10933132)

  • 21. Comparative disposition of codeine and pholcodine in man after single oral doses.
    Findlay JW; Fowle AS; Butz RF; Jones EC; Weatherley BC; Welch RM; Posner J
    Br J Clin Pharmacol; 1986 Jul; 22(1):61-71. PubMed ID: 3741728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation, structure characterization and quantification of related impurities in asperosaponin VI.
    Ji D; Liu YF; Wang QH; Zhang CF; Yang ZL
    Chin J Nat Med; 2013 Jul; 11(4):419-26. PubMed ID: 23845554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Approach for the Simultaneous Determination of Carbinoxamine Maleate, Pholcodine, and Ephedrine Hydrochloride Without Interference from Coloring Matter in an Antitussive Preparation Using Smart Spectrophotometric Methods.
    Moustafa AA; Hegazy MA; Mohamed D; Ali O
    J AOAC Int; 2018 Mar; 101(2):414-426. PubMed ID: 28766478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural characterization of impurities in pioglitazone.
    Kumar YR; Reddy AR; Eswaraiah S; Mukkanti K; Reddy MS; Suryanarayana MV
    Pharmazie; 2004 Nov; 59(11):836-9. PubMed ID: 15587582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of the process-related impurities in fasudil hydrochloride by hyphenated techniques using a quality by design approach.
    Song M; Chen YQ; Lu PB; Hang TJ
    J Sep Sci; 2014 Apr; 37(7):758-63. PubMed ID: 24470347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation, identification and characterization of novel process-related impurities in flupirtine maleate.
    Zhang D; Song X; Su J
    J Pharm Biomed Anal; 2014 Mar; 90():27-34. PubMed ID: 24333703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Semi-preparative LC-SPE-cryoflow NMR for impurity identifications: use of mother liquor as a better source of impurities.
    Rinaldi F; Fan J; Pathirana C; Palaniswamy V
    Magn Reson Chem; 2013 Sep; 51(9):517-22. PubMed ID: 23788325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of pholcodine in man.
    Maurer HH; Fritz CF
    Arzneimittelforschung; 1990 May; 40(5):564-6. PubMed ID: 2383296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analytical and preparative chromatographic procedures for obtaining pure cresyl violet and cresyl red from commercial cresyl violet.
    Urrutia MN; Ortiz CS
    Biotech Histochem; 2015 Apr; 90(3):159-66. PubMed ID: 25358291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of impurity profiles of drugs and related materials. 12. Isolation and identification of an isomeric impurity in danazol.
    Balogh G; Csizér E; Ferenczy GG; Halmos Z; Herényi B; Horváth P; Laukó A; Görög S
    Pharm Res; 1995 Feb; 12(2):295-8. PubMed ID: 7784348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation between pholcodine and perioperative anaphylaxis].
    Dumancić J; Marković AS
    Acta Med Croatica; 2012 May; 66(2):111-4. PubMed ID: 23437637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural studies of racecadotril and its process impurities by NMR and mass spectroscopy.
    Reddy KM; Babu JM; Sudhakar P; Sharma MS; Reddy GS; Vyas K
    Pharmazie; 2006 Dec; 61(12):994-8. PubMed ID: 17283655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and quantitative determination of impurities in piperaquine phosphate by HPLC and LC/MS/MS.
    Dongre VG; Karmuse PP; Ghugare PD; Gupta M; Nerurkar B; Shaha C; Kumar A
    J Pharm Biomed Anal; 2007 Jan; 43(1):186-95. PubMed ID: 16916594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation, structure elucidation, and high-performance liquid chromatography quantification of photolytic degradation impurities in acrivastine.
    Lv JJ; Yu J; Zeng XY; Zeng X; Li Y; He DX; Lin YM
    J Sep Sci; 2022 Sep; 45(18):3480-3490. PubMed ID: 35853230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry.
    Dongre VG; Karmuse PP; Ghugare PD; Kanojiya SK; Rawal S
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2227-33. PubMed ID: 18543378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of impurities in methotrexate drug substances using high-performance liquid chromatography coupled with a photodiode array detector and Fourier transform ion cyclotron resonance mass spectrometry.
    Wu CS; Tong YF; Wang PY; Wang DM; Wu S; Zhang JL
    Rapid Commun Mass Spectrom; 2013 May; 27(9):971-8. PubMed ID: 23592199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of new impurities in rivastigmine.
    Srinivasa Rao M; Rao SV; Srinivasa Rao DV; Bharathi Ch; Rajput P; Sharma HK
    Pharmazie; 2010 May; 65(5):336-8. PubMed ID: 20503924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Estimation of impurity profiles of drugs and related materials. 20. Methodological problems in the identification and determination of organic impurities].
    Görög S
    Acta Pharm Hung; 2000; 70(3-6):131-7. PubMed ID: 11379019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.